User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

Interactions with Platform & by Email *

INTERACTIONS

Unique # Participated *

PARTICIPANTS

Responses Validated *

VALIDATIONS

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Table 1: Global Coronary Heart Disease Prevalence by Region (includes corresponding Graph/Chart).....II-1
Interventional Cardiology: An Introduction.....II-1
1$350
   Coronary Artery Disease – The Leading Cause for Interventional Cardiology
  Procedures.....II-2
Table 2: Deaths Due to Major Cardiovascular Diseases in the US: Percentage Share Breakdown by Disease Type (includes corresponding Graph/Chart).....II-2
Market Estimates and Forecasts.....II-2
1$350
   Geographic Market Performance.....II-3
Product Segment Review.....II-3
Market Overview.....II-3
1$100
   Interventional Cardiology Technology Prospects.....II-4
Coronary Stents - The Leading Interventional Cardiology Device Segment.....II-4
Table 3: World Coronary Stents Market (2007-2010): Percentage Breakdown of Value Sales by Stent Type for Bare-Metal Stents and Drug-eluting Stents (includes corresponding Graph/Chart).....II-4
1$350
   Table 4: World Bare Metal Stents Market (2007-2010): Percentage Breakdown of Value Sales by Geographic Region - US, Japan, Europe, Asia-Pacific and Rest of World (includes corresponding Graph/Chart).....II-5
Drug-Eluting Stents – The Best-Selling Coronary Stents.....II-5
1$350
   Table 5: World Drug-Eluting Stents Market (2007-2010): Percentage Breakdown of Value Sales by Geographic Region - US, Japan, Europe, Asia-Pacific and Rest of World (includes corresponding Graph/Chart).....II-6
Drug-Eluting Stents Market Bounces Back.....II-6
1$350
   Cypher And Taxus Dominate Global DES Market.....II-7
Drug Eluting Stent System – Safety Concerns.....II-7
Bare Metal Coronary Stents.....II-7
IVUS Devices – The Fastest Growing Segment.....II-7
1$100
   Vascular Sealings – A Fast Growing IC Segment.....II-8
Future Prospects Of Vascular Sealings.....II-8
Embolic Protection Devices – Improving PCI Outcomes In SVG Procedures.....II-8
1$100
   DES Opportunities For Smaller Players.....II-91$100
   Aging Population Propels Coronary Stent Market.....II-10
Table 6: Aging Population in the US by Age Group for Years 1990-2030 (includes corresponding Graph/Chart).....II-10
Next Generation Stents – A Boon for Treating Coronary Diseases.....II-10
1$350
   Balloon Angioplasty Wins Edge Over Conventional Bypass Surgery.....II-11
Interventional Cardiology Procedural Volume Recording Steady Growth.....II-11
Technological Advancements to Drive Growth.....II-11
1$100
   Lack of Pharmacological Alternatives Boost Demand for Cardiovascular Catheters.....II-12
Molding Material and Technology Advancements.....II-12
Diagnostic Catheters – Advance from the Workhorse 8 Fr......II-12
Smaller Shafts and Colors – The New in Catheters.....II-12
1$100
   Coronary Stents Market Challenged by Drug Therapy.....II-13
PTCA Catheters – Affected by Direct Stenting.....II-13
Angioplasty – Under Price Pressure.....II-13
Restenosis – The Unsolved Problem.....II-13
1$100
   Cell Transplantation – A Major Threat to Coronary Stents.....II-14
Repeat Interventional Procedures Affected by the Advent of Drug-Eluting Stents.....II-14
Energy-Based Solutions Compete with Conventional Interventional Systems.....II-14
New Pharmacological Therapies Minimizing the Need for Interventional
  Procedures.....II-14
1$100
   The BIG Four.....II-15
Major Interventional Cardiology Device Players.....II-15
1$100
   Coronary Stents – Leading Players.....II-16 1$100
   Table 7: World Coronary Stents Market by Leading Players (2009-2011): Market Share Breakdown for Boston Scientific, Abbott/Guidant, Johnson & Johnson , Medtronic, and Others (includes corresponding Graph/Chart).....II-171$350
   Bare Metal Stents – Leading Players.....II-18
Table 8: World Bare Metal Stents Market (2009-2011): Percentage Breakdown of Revenues by Leading Players - Abbott/ Guidant, Medtronic, Boston Scientific, Johnson & Johnson and Others (includes corresponding Graph/Chart).....II-18
1$350
   Drug-Eluting Stents – Leading Players.....II-19
Table 9: World Drug Eluting Stents Market (2009-2011): Market Share Breakdown by Leading Players - Boston Scientific, Abbott/ Guidant, Johnson & Johnson, Medtronic and Others (includes corresponding Graph/Chart).....II-19
1$350
   Cardiology.....II-20
Interventional Cardiology.....II-20
The Ideal Candidate for Interventional Cardiology.....II-20
1$100
   Interventional Cardiology Benefits.....II-21
Interventional Cardiology Risks.....II-21
Certain Cardiovascular Diseases for Interventional Cardiology.....II-21
Coronary Artery Disease.....II-21
1$100
   Peripheral Arterial Disease.....II-22
Heart Valve Disease.....II-22
Interventional Cardiology Procedures.....II-22
Cardiac Catheterization.....II-22
1$100
   Coronary Angioplasty.....II-23
Table 10: World Angioplasty and Stent Procedures in Millions (2007-2011) (includes corresponding Graph/Chart).....II-23
Valvuloplasty.....II-23
1$350
   Percutaneous Valve Replacement.....II-24
Coronary Thrombectomy.....II-24
Cardiac Ablation.....II-24
Atherectomy.....II-24
1$100
   Interventional Cardiology Devices.....II-25
Coronary Stents.....II-25
Bare Metal Stents.....II-25
Select Leading Bare-Metal Stents by Company.....II-25
1$100
   Drug Eluting Stents.....II-26
Select Leading Drug-Eluting Stents by Company.....II-26
1$100
   Drugs for Coating DESs.....II-27
Select Leading Coronary Stent Brands.....II-27
Cypher.....II-27
Structure and Delivery Mechanism.....II-27
Taxus.....II-27
1$100
   Structure and Delivery Mechanism.....II-28
Catheters.....II-28
Angiography Catheters.....II-28
1$100
   PTCA Catheters.....II-29
Types of Balloon Catheters.....II-29
Rapid -Exchange PTCA Balloon Catheter.....II-29
Over-The-Wire PTCA Balloon Catheter.....II-29
1$100
   Peripheral Devices.....II-30
Intravascular Ultrasound.....II-30
Vascular Sealings/ Vascular Closure Devices.....II-30
Embolic Protection Devices.....II-30
1$100
   Others.....II-31
Atherectomy Catheters.....II-31
Guide Catheters.....II-31
Guidewires.....II-31
1$100
   Conditional IDE Approval for ORBIT II Clinical Trial with Diamondback 360®
  System.....II-32
US FTC Approves Getinge and Datascope Merger.....II-32
1$100
   Xtent Obtains CE Mark for Custom NX Drug-Eluting Stent System.....II-33
Invatec Obtains CE Mark for IN.PACT Falcon Paclitaxel-Eluting PTCA Balloon
  Catheter.....II-33
Medtronic Obtains Approval for Endeavor in Japan.....II-33
Atrium Medical Gains EU Approval for Cinatra™.....II-33
Boston Scientific Obtains FDA Approval for TAXUS® Liberte®.....II-33
1$100
   Boston Scientific Obtains FDA Approval for Taxus® Express2™.....II-34
Health Canada Approves Abbott’s XIENCE V®.....II-34
Angiotech Receives CE Certification for Zilver® PTX® Stent.....II-34
NMT Medical Obtains PMA Approval from US FDA for STARFlex® Implant.....II-34
Cordis Receives FDA Approval for a Smaller Version of CYPHER® Stent.....II-34
1$100
   Boston Scientific Receives CE Mark for PROMUS® Element™.....II-35
Biosensors International Obtains CE Mark for Small- Diameter BioMatrix Stent.....II-35
AGA Medical Receives CE Mark for AMPLATZER® Cardiac Plug.....II-35
1$100
   AGA Medical Gains CE Mark Approval for AMPLATZER® Vascular Plug III.....II-36
AGA Medical Gets CE Mark for AMPLATZER® Duct Occluder II.....II-36
Cook Medical Receives FDA Clearance for Balloon Dilatation Catheter.....II-36
Cardiac Dimensions® Receives CE Mark for Carillontm Mitral Contour System™.....II-36
1$100
   Medtronic Receives the US FDA Approval to Use Endeavor® Stent.....II-37
Boston Scientific to Market TAXUS® Liberte® Stent System in Canada.....II-37
Global Therapeutics Receives CE Mark for Global Therapeutics GTX Coronary Stent
  System.....II-37
OrbusNeich Obtains CE Mark.....II-37
1$100
   Abbott’s 2.25mm-Sized XIENCE™ V Drug Eluting Stent receives CE Mark of
  Approval.....II-38
Cook Medical Gains CE Mark Approval for MiraFlex™ High Flow Microcatheter.....II-38
Terumo Receives CE Certification for Nobori™ DEC Stent System.....II-38
Abbott Applies for Approval of XIENCE™ V in Japan.....II-38
1$100
   Tryton Medical’s Side-Branch Stent Achieves CE Mark Approval.....II-39
MIV Therapeutics Obtains DCGI Approval.....II-39
Cook Medical’s Zilver Stent Receives Approval for Vascular Use In Canada.....II-39
1$100
   Boston Scientific Introduces iCross Coronary Imaging Catheter.....II-40
Boston Scientific Launches TAXUS® Liberte® DES System in Japan.....II-40
Abbott Introduces VOYAGER™ NC Coronary Balloon Catheter.....II-40
Invatec Introduces Coronary Drug-Eluting Balloon Platform IN.PACT.....II-40
1$100
   Terumo Launches Glidewire Advantage™ Peripheral Guidewire.....II-41
Invatec Launches REEF HPTM PTA Balloon Catheter.....II-41
Tryton Medical Launches Side-Branch Stent.....II-41
Terumo Interventional Systems Introduces Coronary Diagnostic Catheters.....II-41
1$100
   Medtronic Launches Endeavor Sprint Drug Eluting Stent.....II-42
Medtronic to Introduce Balloon Catheters and Coronary Stents.....II-42
Cordis Introduces SAVVY® and SLEEK™ Balloon Catheters.....II-42
Volcano Launches Integrated FFR and Rotational IVUS.....II-42
Medtronic Launches Defender Embolic Protection Filter.....II-42
1$100
   Biosensors Introduces BioMatrix® Drug-Eluting Stent.....II-43
St. Jude Medical Unveils Refllexion Spiral XTM Catheter.....II-43
Volcano Launches PrimeWire™ Pressure Guidewire and s5-FFR Option for Existing Fleet of
  s5 IVUS Consoles.....II-43
1$100
   Medtronic to Acquire Invatec.....II-44
Lake Region Medical Acquires Brivant Medical.....II-44
Abbott Acquires Evalve.....II-44
1$100
   Texcel and Circle Medical Announce Merger.....II-45
Volcano and Lumen Biomedical Enter into Distribution Agreement.....II-45
Volcano Enters into Alliance with Siemens Healthcare.....II-45
1$100
   Spectranetics Acquires Embolic Protection Products from Kensey Nash.....II-46
MEDRAD Merges With Possis Medical.....II-46
St. Jude Medical to Acquire RadiMedical.....II-46
St. Jude Medical Acquires EP MedSystems.....II-46
1$100
   Volcano Takes Over Novelis.....II-47
Heraeus Vadnais Takes Over Synovis Life Technologies.....II-47
Novation Signs Deal with Medtronic for Endeavor Zotarolimus DES.....II-47
1$100
   Boston Scientific Enter into Agreement with Trivitron.....II-48
Volcano and Royal Philips Electronics Sign North America Resale Agreement.....II-48
MMDIA Receives Patent Allowance for BetaWire™ Guidewire.....II-48
Cordis to Market ClearStream Technologies’ Catheters.....II-48
1$100
   Abbott Laboratories Acquires Nova Science.....II-491$100
   Abbott Laboratories (US).....II-50
Abbott Vascular (US).....II-50
AGA Medical Holdings, Inc. (US).....II-50
1$100
   B. Braun Melsungen AG (Germany).....II-51
Biosensors International Group Ltd. (Singapore).....II-51
Boston Scientific Corp. (US).....II-51
1$100
   Cardiac Dimensions, Inc. (US).....II-52
COOK Medical, Inc. (US).....II-52
1$100
   Cordis Corp. (US).....II-53
Edwards Lifesciences Corp. (US).....II-53
Eurocor GmbH (Germany).....II-53
ev3, Inc. (US).....II-53
1$100
   Goodman Co., Ltd. (Japan).....II-54
Medtronic, Inc. (US).....II-54
1$100
   Medtronic Vascular, Inc. (US).....II-55
Merit Medical Systems, Inc. (US).....II-55
NMT Medical (US).....II-55
1$100
   Spectranetics Corp. (US).....II-56
St. Jude Medical, Inc. (US).....II-56
Terumo Corp. (Japan).....II-56
1$100
   Terumo Medical Corporation (Japan).....II-57
Thermocore Medical Limited (UK).....II-57
Translumina GmbH (Germany).....II-57
Vascular Solutions, Inc. (US).....II-57
1$100
   Volcano Corp. (US).....II-581$100
   Table 11: World Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - US, Japan, Europe, Asia-Pacific (Excl. Japan) and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-591$350
   Table 12: World 10-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Dollar Sales for US, Japan, Europe, Asia-Pacific (Excl. Japan) and Rest of World Markets for Years 2006, 2009 and 2015 (includes corresponding Graph/Chart).....II-601$350
   Table 13: World Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Product Segment -Coronary Stents, Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, Vascular Sealings and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-611$350
   Table 14: World 10-Year Perspective for Interventional Cardiology Devices by Product Segment - Percentage Breakdown of Dollar Sales for Coronary Stents, Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, Vascular Sealings and Others Markets for Years 2006, 2009 and 2015 (includes corresponding Graph/Chart).....II-621$350
   A. Market Analysis.....III-1
Coronary Artery Disease.....III-1
Table 15: The Ten Leading Causes of Death in the US (includes corresponding Graph/Chart).....III-1
1$200
   Coronary Heart Disease Statistics.....III-2
Rising Obesity Levels Increase Number of Interventional Cardiology
  Procedures.....III-2
Current and Future Analysis.....III-2
Market Overview.....III-2
1$75
   Coronary Stents Market.....III-3
Table 16: Angioplasty and Stent Procedures Performed in the US: 2006-2011 (In Thousands) (includes corresponding Graph/Chart).....III-3
1$200
   Table 17: US Coronary Stents Market (2006-2011): Number of Stents Used in Angioplasty Procedures by Stent Type (in Thousands) (includes corresponding Graph/Chart).....III-4
The Emergence, Rise, Fall and Re-emergence of Drug Eluting Stents.....III-4
1$200
   The Angioplasty and Stents Debate Continues.....III-5
The Role of Pharmacists.....III-5
The Huge Potential.....III-5
1$75
   Table 18: US Drug Eluting Stents Market (2009): Market Share Breakdown of Value Sales by Leading Brands - Cypher, Endeavor, Taxus, Promus and Xience (includes corresponding Graph/Chart).....III-6
Product Approvals.....III-6
3$200
   Product Launches.....III-91$75
   Strategic Corporate Developments.....III-102$125
   Select Players.....III-127$325
   B. Market Analytics.....III-19
Table 19: US Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-19
1$200
   A. Market Analysis.....III-20
Current and Future Analysis.....III-20
Market Overview.....III-20
Coronary Stents – The Leading IC Device Segment.....III-20
US Companies Lead Japanese IC Device Market.....III-20
1$75
   Table 20: Japanese Coronary Stents Market (2007): Market Share Breakdown of Value Sales by Major Players - Johnson & Johnson, Boston Scientific, Abbott/Guidant, Medtronic and Others (in US$ Million) (includes corresponding Graph/Chart).....III-21

Table 21: Japanese Bare-Metal Stents Market (2007): Market Share Breakdown of Value Sales by Major Players - Medtronic, Abbott/Guidant, Johnson & Johnson, Boston Scientific,and Others (includes corresponding Graph/Chart).....III-21
Drug-Eluting Stents.....III-21
1$200
   Table 22: Japanese Coronary Drug-Eluting Stents Market (2009): Market Share Breakdown of Value Sales by Major Player Johnson & Johnson, Boston Scientific and Medtronic (includes corresponding Graph/Chart).....III-22
Product Approvals.....III-22
1$200
   Product Launches.....III-23
Select Players.....III-23
2$125
   B. Market Analytics.....III-25
Table 23: Japanese Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-25
1$200
   A. Market Analysis.....III-26
Current and Future Analysis.....III-26
Market Overview.....III-26
The DES Market.....III-26
1$75
   Table 24: European Coronary Stent Market (2007): Market Share Breakdown of Value Sales by Company - Boston Scientific, Johnson & Johnson, Medtronic, Abbott and Others (includes corresponding Graph/Chart).....III-27

Table 25: European Coronary Drug-Eluting Stent Market (2007): Market Share Breakdown of Value Sales by Company - Boston Scientific, Johnson & Johnson, Medtronic, Abbott and Others (includes corresponding Graph/Chart).....III-27

Table 26: European Coronary Bare-Metal Stent Market (2007): Market Share Breakdown of Value Sales by Company - Abbott, Medtronic, Boston Scientific, Johnson & Johnson, and Others (includes corresponding Graph/Chart).....III-27
1$200
   Technology Innovation Drives PCI Devices Market in Western Europe.....III-28
Table 27: Western Europe PCI (Percutaneous Coronary Intervention) Market (2008): Percentage Breakdown of Sales in Value Terms for Boston Scientific, Cordis, Medtronic, Abbott and Others (includes corresponding Graph/Chart).....III-28
1$200
   Table 28: Western Europe Coronary Stent Market (2008) by Stent Type: Percentage Breakdown of Sales in Value Terms for Drug-Eluting Stents and Bare Metal Stents (includes corresponding Graph/Chart).....III-29

Table 29: Western Europe Coronary Stent Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Boston Scientific, Cordis, Medtronic, Abbott and Others (includes corresponding Graph/Chart).....III-29

Table 30: Western Europe Angioplasty Balloon Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Biotronik, ClearStream, Invatec and Others (includes corresponding Graph/Chart).....III-29
1$200
   Table 31: Western Europe Coronary Catheters Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Cordis, Boston Scientific, Medtronic, Abbott, St. Jude Medical and Others (includes corresponding Graph/Chart).....III-30

Table 32: Western Europe Coronary Guidewires Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Cordis, Boston Scientific, Abbott, Medtronic, St. Jude Medical and Others (includes corresponding Graph/Chart).....III-30

Table 33: Western Europe Balloon Inflators Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Medtronic, Abbott, Merit Medical, B. Braun and Others (includes corresponding Graph/Chart).....III-30
1$200
   Table 34: Western Europe Embolic Protection Devices Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Boston Scientific, Medtronic, Abbott, St. Jude Medical and Others (includes corresponding Graph/Chart).....III-31
Product Approvals.....III-31
4$200
   Product Launches.....III-351$75
   Strategic Corporate Developments.....III-361$75
   Select Players.....III-372$125
   B. Market Analytics.....III-39
Table 35: European Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-39
1$200
   A. Market Analysis.....III-40
Current and Future Analysis.....III-40
Market Overview.....III-40
Table 36: Asia-Pacific Drug Eluting Stents Market (2007): Percentage Breakdown of Value Sales for China, Korea, India, Australia and Others (includes corresponding Graph/Chart).....III-40
1$200
   Table 37: Asia-Pacific Drug Eluting Stents Market (2007): Market Share Breakdown by Leading Players - Microport, Cordis, JW Medical ,Boston Scientific and Others (includes corresponding Graph/Chart).....III-411$200
   B. Market Analytics.....III-42
Table 38: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - China, India, Korea, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-42
1$200
   Table 39: Asia-Pacific 10-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Dollar Sales for China, India, Korea, and Rest of Asia-Pacific Markets for Years 2006, 2009, and 2015 (includes corresponding Graph/Chart).....III-431$200
   A. Market Analysis.....III-44
Current and Future Analysis.....III-44
Market Overview.....III-44
Growth Drivers and Restrains.....III-44
Healthcare Reforms to Drive Drug-Eluting Stents Growth.....III-44
1$75
   B. Market Analytics.....III-45
Table 40: Chinese Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-45
1$200
   A. Market Analysis.....III-46
Current and Future Analysis.....III-46
Market Overview.....III-46
Imported Stents Hold Great Prospects.....III-46
Availability of Enhanced DES Ensures Quality Care for Heart Patients.....III-46
1$75
   Product Approval.....III-47
Strategic Corporate Developments.....III-47
1$75
   B. Market Analytics.....III-48
Table 41: Indian Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-48
1$200
   A. Market Analysis.....III-49
Current and Future Analysis.....III-49
Market Outlook.....III-49
Market Overview.....III-49
US Companies Dominate Supply Landscape.....III-49
1$75
   Korean Imports of Interventional Cardiology Devices: Breakdown by Select Countries
  of Origin.....III-50
Table 42: Korean Interventional Coronary Artery Devices Market (2007-2009): Number of Procedures for Diagnostic Angiography, and PTCA Procedures (In Thousands) (includes corresponding Graph/Chart).....III-50
1$200
   B. Market Analytics.....III-51
Table 43: Korean Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Product Segment - Drug Eluting Stents, Intravascular Ultrasound, Guiding Catheters, Balloon Catheters, PTCA Guidewires, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-51
1$200
   Table 44: Korean 10-Year Perspective for Interventional Cardiology Devices by Product Segment - Percentage Breakdown of Dollar Sales for Drug Eluting Stents, Intravascular Ultrasound, Guiding Catheters, Balloon Catheters, PTCA Guidewires, and Others Markets for Years 2006, 2009, and 2015 (includes corresponding Graph/Chart).....III-521$200
   A. Market Analysis.....III-53
Current and Future Analysis.....III-53
Product Approval.....III-53
Select Player.....III-53
1$75
   B. Market Analytics.....III-54
Table 45: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-54
1$200
   A. Market Analysis.....III-55
Current and Future Analysis.....III-55
Product Approvals.....III-55
1$75
   Product Launch.....III-56
B. Market Analytics.....III-56
Table 46: Rest of World Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-56
1$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com